658 results
Page 13 of 33
8-K
EX-99.1
xb6g3u4z
24 Oct 12
Other Events
12:00am
8-K
g5of 7h4nxnr
10 Aug 12
Termination of a Material Definitive Agreement
12:00am
8-K
EX-99.1
68d7zi 0mgxb2v
2 Aug 12
Discovery Labs Reports Second Quarter 2012 Financial Results
12:00am
8-K
pmrns
2 Aug 12
Discovery Labs Reports Second Quarter 2012 Financial Results
12:00am
8-K/A
mvy8ngd87uss7
29 Jun 12
Entry into a Material Definitive Agreement
12:00am
8-K
2ihb019
28 Jun 12
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.1
a4rmn2a4kpf 48s
11 May 12
Departure of Directors or Certain Officers
12:00am
8-K/A
30i2ur4 9393vcrhv
11 May 12
Departure of Directors or Certain Officers
12:00am
8-K
f1ux5t2gn1w7lorz
3 May 12
Discovery Labs Reports First Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
s9g hdlw62scy
3 May 12
Discovery Labs Reports First Quarter 2012 Financial Results
12:00am
8-K
2oof6 40v
29 Mar 12
Discovery Labs Reports Fourth Quarter Financial Results and Highlights Recent Milestones
12:00am
8-K
EX-99.1
d80qzc
29 Mar 12
Discovery Labs Reports Fourth Quarter Financial Results and Highlights Recent Milestones
12:00am
424B5
09tmw0hwix
19 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
lbs4xc4a3u xc
16 Mar 12
Discovery Labs Prices $45.0 Million Public Offering of
12:00am
424B5
cehmk16fqvl
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
05mwi7r4vgrb768ec
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am